IBSA Derma expands into Australia and New Zealand

30 Sep 2022

Pharmaceutical company IBSA Derma has launched its Profhilo line in Australia and New Zealand.

During a tour in Sydney, Melbourne and Adelaide, IBSA presented its products and technologies to industry professionals and to several hundred scientific and business partners, supported by international and regional key opinion leaders including Mr Dalvi Humzah, Dr Gabriel Siquier, Dr Cara McDonald, Dr Steven Liew and Dr Robin Chock.

Leo Magnani, international sales manager at IBSA, said, “Australia and New Zealand are key markets for IBSA’s expansion journey on the international scene that confirms the successful strategic choice of enhancing authentic beauty. The uniqueness of our innovative products has allowed us to also achieve immediate commercial success right from the launch that took place last August.”  


Log-in to post a comment